5/18/22 18:02 | 5/18/22 | SNGX | Health | Drug | Pharmaceutical Preparations | Straube Richard | NJ | O | SVP,CMO | P | 4 | 0.5000 | 0 | 8 | New | 8 | D | | | | | | | | | | | | | | |
5/18/22 18:01 | 5/18/22 | SNGX | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | NJ | DO | CB,CEO,P | P | 9 | 0.4433 | 0 | 20 | 29 | 90 | D | | | | | | | | | | | | | | |
12/20/21 16:23 | 12/17/21 | SNGX | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | NJ | DO | CB,CEO,P | P | 5 | 0.7399 | 0 | 7 | 11 | 70 | D | | | | | | | | | | | | | | |
12/15/21 16:05 | 12/15/21 | SNGX | Health | Drug | Pharmaceutical Preparations | Guarino Jonathan L. | NJ | O | SVP,CFO | P | 1 | 0.7000 | 0 | 1 | 10 | 11 | D | | | | | | | | | | | | | | |
12/15/21 07:20 | 12/14/21 | SNGX | Health | Drug | Pharmaceutical Preparations | Guarino Jonathan L. | NJ | O | SVP,CFO | P | 7 | 0.7119 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
12/14/21 16:05 | 12/14/21 | SNGX | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | NJ | DO | CB,CEO,P | P | 7 | 0.7269 | 0 | 10 | 19 | 63 | D | | | | | | | | | | | | | | |
5/18/21 17:00 | 5/14/21 | SNGX | Health | Drug | Pharmaceutical Preparations | Zeldis Jerome B | NJ | D | | P | 3 | 0.8880 | 0 | 3 | 15 | 23 | D | | | | | | | | | | | | | | |
11/19/19 16:19 | 11/19/19 | SNGX | Health | Drug | Pharmaceutical Preparations | Zeldis Jerome B | NJ | D | | P | 2 | 0.9250 | 0 | 2 | 10 | 23 | D | | | | | | | | | | | | | | |
11/19/19 16:18 | 11/19/19 | SNGX | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | NJ | DO | CB,CEO,P | P | 10 | 0.9300 | 0 | 11 | 25 | 53 | D | | | | | | | | | | | | | | |
9/23/19 19:15 | 9/23/19 | SNGX | Health | Drug | Pharmaceutical Preparations | Parks Diane L. | NJ | D | | P | 14 | 0.9284 | 0 | 15 | New | 15 | D | | | | | | | | | | | | | | |
9/23/19 16:19 | 9/19/19 | SNGX | Health | Drug | Pharmaceutical Preparations | Zeldis Jerome B | NJ | D | | P | 4 | 0.9350 | 0 | 4 | 24 | 21 | D | | | | | | | | | | | | | | |
4/22/19 16:41 | 4/22/19 | SNGX | Health | Drug | Pharmaceutical Preparations | Zeldis Jerome B | NJ | D | | P | 7 | 0.7274 | 0 | 10 | 145 | 17 | D | | | | | | | | | | | | | | |
4/22/19 16:41 | 4/22/19 | SNGX | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | NJ | DO | CB,CEO,P | P | 4 | 0.7154 | 0 | 5 | 13 | 42 | D | | | | | | | | | | | | | | |
10/18/18 16:51 | 10/18/18 | SNGX | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | NJ | DO | CB,CEO,P | P | 10 | 1.17 | 0 | 9 | 30 | 37 | D | | | | | | | | | | | | | | |
10/17/18 20:09 | 10/17/18 | SNGX | Health | Drug | Pharmaceutical Preparations | Pearson Mark E. | NJ | D | | P | 197 | 1.16 | 0 | 170 | 7 | 2,500 | D | | | | | | | | | | | | | | |
8/22/18 17:00 | 8/22/18 | SNGX | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | NJ | DO | CB,CEO,P | P | 5 | 1.42 | 0 | 4 | 14 | 29 | D | | | | | | | | | | | | | | |
12/1/17 16:25 | 11/29/17 | SNGX | Health | Drug | Pharmaceutical Preparations | Essetifin Spa | L6 | H | Former 1 | P | 622 | 2.12 | 0 | 294 | New | 294 | M | | | | | | | | | | | | | | |
12/20/16 10:02 | 12/16/16 | SNGX | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | NJ | DO | CB,CEO,P | P.d | 50 | 3.16 | 0 | 16 | 170 | 25 | D | -82 | -77 | -65 | -67 | -38 | -38 | -20 | 6 | 2 | -3 | 0 | -6 | | |
12/20/16 10:01 | 12/16/16 | SNGX | Health | Drug | Pharmaceutical Preparations | Rubin Robert J. | NJ | D | | P.d | 10 | 3.16 | 0 | 3 | 259 | 4 | D | -82 | -77 | -65 | -67 | -38 | -38 | -20 | 6 | 2 | -3 | 0 | -6 | | |
12/20/16 10:00 | 12/16/16 | SNGX | Health | Drug | Pharmaceutical Preparations | Brughera Marco Maria | NJ | D | | P.d | 6 | 3.16 | 0 | 2 | 267 | 3 | D | -82 | -77 | -65 | -67 | -38 | -38 | -20 | 6 | 2 | -3 | 0 | -6 | | |
12/23/15 10:04 | 12/23/15 | SNGX | Health | Drug | Pharmaceutical Preparations | Zeldis Jerome B | NJ | D | | P | 3 | 1.27 | 0 | 3 | 4 | 69 | D | -31 | 23 | -50 | 19 | 19 | 37 | 140 | 45 | -9 | -6 | -19 | -32 | -44 | -80 |
12/23/15 06:02 | 12/22/15 | SNGX | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | NJ | DO | CB,CEO,P | P | 13 | 1.29 | 0 | 10 | 13 | 86 | D | -31 | 23 | -50 | 19 | 19 | 37 | 140 | 45 | -9 | -6 | -19 | -32 | -44 | -80 |
12/24/14 10:06 | 12/22/14 | SNGX | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | NJ | DO | CB,CEO,P | P.d | 10 | 1.21 | 0 | 8 | 12 | 76 | D | 76 | -43 | -52 | -49 | -46 | -33 | -27 | -24 | -1 | -4 | 6 | 63 | 135 | 12 |
12/24/14 10:05 | 12/22/14 | SNGX | Health | Drug | Pharmaceutical Preparations | Warusz Joseph Michael | NJ | O | VP of Fi | P.d | 10 | 1.21 | 0 | 8 | 176 | 13 | D | 76 | -43 | -52 | -49 | -46 | -33 | -27 | -24 | -1 | -4 | 6 | 63 | 135 | 12 |
6/26/13 16:18 | 6/25/13 | SNGX | Health | Drug | Pharmaceutical Preparations | Zeldis Jerome B | NJ | D | | P.d | 25 | 1.05 | 0 | 24 | 95 | 49 | D | -76 | 220 | 66 | -27 | -30 | -45 | -40 | -36 | 6 | 0 | 46 | 120 | 83 | 119 |
6/26/13 16:18 | 6/25/13 | SNGX | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | NJ | DO | CB,CEO,P | P.d | 10 | 1.05 | 0 | 10 | 19 | 60 | D | -76 | 220 | 66 | -27 | -30 | -45 | -40 | -36 | 6 | 0 | 46 | 120 | 83 | 119 |
6/26/13 16:17 | 6/25/13 | SNGX | Health | Drug | Pharmaceutical Preparations | Brownlie Keith L | NJ | D | | P.d | 20 | 1.05 | 0 | 19 | New | 19 | D | -76 | 220 | 66 | -27 | -30 | -45 | -40 | -36 | 6 | 0 | 46 | 120 | 83 | 119 |
4/11/12 19:12 | 4/10/12 | SNGX | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | NJ | DO | CB CEO,P | P | 5 | 0.5098 | 0 | 10 | 25 | 50 | D | -91 | -88 | -40 | -20 | -23 | -9 | -4 | 7 | 0 | 0 | -25 | -23 | 29 | 196 |
8/20/10 14:00 | 8/18/10 | SNGX | Health | Drug | Pharmaceutical Preparations | Bam Management LLC | NY | T | | P | 38 | 0.2400 | 0 | 160 | 1 | 21,574 | I | 144 | 0 | -15 | -15 | -12 | -12 | -15 | -8 | 9 | 5 | 5 | -23 | -18 | 23 |
6/22/10 12:11 | 6/18/10 | SNGX | Health | Drug | Pharmaceutical Preparations | Lapointe Anthony Gregg | NJ | D | | P.d | 200 | 0.2050 | 0 | 976 | New | 976 | D | 85 | 33 | 14 | -14 | -14 | -8 | -4 | 0 | 8 | 4 | 0 | -4 | -38 | -21 |
6/22/10 10:25 | 6/18/10 | SNGX | Health | Drug | Pharmaceutical Preparations | Rubin Robert J. | NJ | D | | P.d | 50 | 0.2050 | 0 | 244 | New | 244 | D | 85 | 33 | 14 | -14 | -14 | -8 | -4 | 0 | 8 | 4 | 0 | -4 | -38 | -21 |
6/21/10 16:59 | 6/18/10 | SNGX | Health | Drug | Pharmaceutical Preparations | Cavazza Claudio | L6 | T | | P.d | 1,765 | 0.2050 | 0 | 8,609 | 19 | 54,228 | I | 85 | 26 | 14 | -14 | -11 | -11 | -8 | -4 | 8 | 8 | 4 | -4 | -38 | -21 |
6/21/10 16:58 | 6/18/10 | SNGX | Health | Drug | Pharmaceutical Preparations | Cavazza Paolo | V8 | T | | P.d | 2,365 | 0.2050 | 0 | 11,535 | | 4,474 | I | 85 | 26 | 14 | -14 | -11 | -11 | -8 | -4 | 8 | 8 | 4 | -4 | -38 | -21 |
6/21/10 16:57 | 6/18/10 | SNGX | Health | Drug | Pharmaceutical Preparations | Sigma Tau Finanziaria Spa | L6 | T | | P.d | 1,765 | 0.2050 | 0 | 8,609 | 19 | 54,228 | I | 85 | 26 | 14 | -14 | -11 | -11 | -8 | -4 | 8 | 8 | 4 | -4 | -38 | -21 |
9/30/09 15:43 | 9/28/09 | SNGX | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | NJ | DO | CEO | P.d | 20 | 0.2530 | 0 | 79 | 20 | 472 | D | -27 | 170 | 145 | 50 | 29 | 42 | 0 | 8 | 4 | 15 | -26 | -7 | 0 | -30 |
9/28/09 13:22 | 9/24/09 | DORB | Health | Drug | Pharmaceutical Preparations | Sigma Tau Finanziaria Spa | L6 | T | | P.d | 1,000 | 0.2530 | 0 | 3,953 | 9 | 45,619 | I | | | | | | | | | | | | | | |
9/28/09 13:21 | 9/24/09 | DORB | Health | Drug | Pharmaceutical Preparations | Cavazza Paolo | V8 | T | | P.d | 1,000 | 0.2530 | 0 | 3,953 | 9 | 47,166 | I | | | | | | | | | | | | | | |
9/28/09 13:20 | 9/24/09 | DORB | Health | Drug | Pharmaceutical Preparations | Cavazza Claudio | L6 | T | | P.d | 1,000 | 0.2530 | 0 | 3,953 | 9 | 45,619 | I | | | | | | | | | | | | | | |
2/13/09 12:20 | 2/11/09 | DORB | Health | Drug | Pharmaceutical Preparations | Sigma Tau Finanziaria Spa | L6 | T | | P | 4,500 | 0.1800 | 0 | 25,000 | 150 | 41,667 | I | | | | | | | | | | | | | | |
2/13/09 12:19 | 2/11/09 | DORB | Health | Drug | Pharmaceutical Preparations | Cavazza Paolo | V8 | T | | P | 4,500 | 0.1800 | 0 | 25,000 | 137 | 43,214 | I | | | | | | | | | | | | | | |
2/13/09 12:18 | 2/11/09 | DORB | Health | Drug | Pharmaceutical Preparations | Cavazza Claudio | L6 | T | | P | 4,500 | 0.1800 | 0 | 25,000 | 150 | 41,667 | I | | | | | | | | | | | | | | |
8/29/07 12:54 | 8/28/07 | DORB | Health | Drug | Pharmaceutical Preparations | Clavijo James | FL | O | Controll | P | 10 | 0.2950 | 0 | 35 | 66 | 88 | D | | | | | | | | | | | | | | |
8/29/07 12:52 | 8/29/07 | DORB | Health | Drug | Pharmaceutical Preparations | Myrianthopoulos Evan | FL | DO | CFO | P | 22 | 0.3096 | 0 | 70 | 45 | 225 | D | | | | | | | | | | | | | | |
8/29/07 12:51 | 8/28/07 | DORB | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | FL | DO | CEO | P | 29 | 0.2906 | 0 | 100 | 34 | 393 | D | | | | | | | | | | | | | | |
2/13/07 07:58 | 2/9/07 | DOR | Health | Drug | Pharmaceutical Preparations | Clavijo James | FL | O | Controll | P.d | 25 | 0.4700 | 0 | 53 | New | 53 | D | | | | | | | | | | | | | | |
2/13/07 07:57 | 2/9/07 | DOR | Health | Drug | Pharmaceutical Preparations | Myrianthopoulos Evan | FL | DO | CFO | P.d | 25 | 0.4700 | 0 | 53 | 52 | 155 | D | | | | | | | | | | | | | | |
2/13/07 07:56 | 2/9/07 | DORB | Health | Drug | Pharmaceutical Preparations | Schaber Christopher J | FL | DO | CEO | P.d | 100 | 0.4700 | 0 | 213 | 266 | 293 | D | | | | | | | | | | | | | | |
2/13/07 07:55 | 2/9/07 | DOR | Health | Drug | Pharmaceutical Preparations | Kanzer Steve H | FL | D | | P.d | 100 | 0.4700 | 0 | 213 | 20 | 1,282 | D | | | | | | | | | | | | | | |
11/26/03 09:29 | 11/25/03 | DOR | Health | Drug | Pharmaceutical Preparations | Kanzer Steve H | FL | D | | P | 4 | 0.7500 | 0 | 5 | 1 | 819 | D | | | | | | | | | | | | | | |